Skip to main content

Table 1 Summary of participants’ characteristics

From: Mass spectrometry detection of inhaled drug in distal fibrotic lung

 

Ipratropium bromide (N* = 7)

Age in Years [Mean (SD)]

62.1 (5.98)

Male [n (%)]

3 (43)

BMI (kg/m2) [Mean (SD)]

31.11 (3.191)

Height (cm) [Mean (SD)]

168.71 (16.039)

FVC [Mean (SD)] 

2.58 (1.161)

% predicted FVC [Mean (SD)] 

73.75 (12.863)

FEV1 [Mean (SD)] 

2.12 (0.773)

% predicted FEV1 [Mean (SD)] 

77.07 (11.256)

MDT diagnosis of study completers

Study completers (N = 5)

IPF/probable IPF [n (%)]

3 (60)

NSIP/fibrotic NSIP [n (%)]

2 (40)

  1. BMI body mass index, FVC forced vital capacity, FEV1 forced expiratory volume at 1 s, MDT multidisciplinary team, IPF idiopathic pulmonary fibrosis, NSIP non-specific interstitial pneumonia
  2. Note 1: *One participant had to be re-enrolled
  3. Note 2: As this was a non-quantitative, proof of concept study the impact of the participant’s characteristics was not designed to be taken into consideration
Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us